{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:10:05Z","timestamp":1790021405464,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clnesp.2026.105004","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:25:37Z","timestamp":1785770737000},"page":"105004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adjunctive nutritional interventions in schizophrenia: A systematic review of randomised clinical trials"],"prefix":"10.1016","volume":"75","author":[{"given":"Beatriz","family":"Braga Concei\u00e7\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thassila Rayssa","family":"Arruda de Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Nunes de Sousa dos Santos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Theophilo Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Cec\u00edlia","family":"R. P. Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-5352","authenticated-orcid":false,"given":"Felipe","family":"de Souza Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.105004_bib1","series-title":"Schizophrenia","year":"2025"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/1516-4446-2015-1827","article-title":"Schizophrenia, the forgotten disorder: the scenario in Brazil","volume":"37","author":"Matos","year":"2015","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.clnesp.2026.105004_bib3","series-title":"Schizophrenia","year":"2024"},{"key":"10.1016\/j.clnesp.2026.105004_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2017.09.005","article-title":"A widening longevity gap between people with schizophrenia and general population: a literature review and call for action","volume":"196","author":"Lee","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clnesp.2026.105004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115480","article-title":"Exercise as an add-on treatment in individuals with schizophrenia: results from a large multicenter randomized controlled trial","volume":"328","author":"Maurus","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clnesp.2026.105004_bib6","series-title":"Data from the Psychosocial Care Network (RAPS) in the Brazilian Unified Health System (SUS)","year":"2022"},{"key":"10.1016\/j.clnesp.2026.105004_bib7","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clnesp.2026.105004_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2026.105004_bib10","series-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 0.4 [updated September 2008]. The Cochrane Collaboration","article-title":"Chapter 7: Searching for Studies","author":"de Vet","year":"2008"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-019-2059-x","article-title":"Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients","volume":"19","author":"Ghaderi","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105004_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/npr2.12431","article-title":"Co-administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: a double-blinded randomized controlled trial","volume":"44","author":"Mohammadi","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.clnesp.2026.105004_bib13","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1007\/s12011-020-02572-3","article-title":"The effects of probiotic and selenium co-supplementation on clinical and metabolic scales in chronic schizophrenia: a randomized, double-blind, placebo-controlled trial","volume":"199","author":"Jamilian","year":"2021","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/schbul\/sbac044","article-title":"Probiotics plus dietary fiber supplements attenuate olanzapine-induced weight gain in drug-na\u00efve first-episode schizophrenia patients: two randomized clinical trials","volume":"48","author":"Huang","year":"2022","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12888-022-04426-9","article-title":"Impact of high prebiotic and probiotic dietary education in the SARS-CoV-2 era: improved cardio-metabolic profile in schizophrenia spectrum disorders","volume":"22","author":"Sevillano-Jim\u00e9nez","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00213-018-5136-9","article-title":"Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial","volume":"236","author":"Xu","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.clnesp.2026.105004_bib17","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-019-05258-4","article-title":"Increased plasma levels of brain-derived neurotrophic factor are related to the efficacy of n-3 polyunsaturated fatty acid in the first episode of schizophrenia: secondary outcome analysis of the randomized clinical trial OFFER","volume":"236","author":"Pawe\u0142czyk","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105004_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ijnp\/pyaa006","article-title":"Resveratrol adjunct therapy for negative symptoms in patients with stable schizophrenia: a double-blind, randomized placebo-controlled trial","volume":"23","author":"Samaei","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105004_bib19","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11826","article-title":"Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"79","author":"Chengappa","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clnesp.2026.105004_bib20","series-title":"Noncommunicable diseases","year":"2025"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105004_bib21","article-title":"Analysis of the consequences that polypharmacy causes in patients with chronic diseases: a literature review","volume":"11","author":"Silva","year":"2022","journal-title":"Res Soc Dev"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105004_bib23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105004_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13679-021-00433-1","article-title":"Vitamin D and obesity: current evidence and controversies","volume":"10","author":"Karampela","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.clnesp.2026.105004_bib25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2026.105004_bib26","doi-asserted-by":"crossref","first-page":"678159","DOI":"10.1155\/2013\/678159","article-title":"Obesity and inflammation: epidemiology, risk factors, and markers of inflammation","volume":"2013","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105004_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105004_bib28","article-title":"Anti-inflammatory action of resveratrol in the central nervous system in relation to glucose concentration: an in vitro study on a blood\u2013brain barrier model","volume":"25","author":"Komorowska-M\u00fcller","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49452-y","article-title":"Defining dysbiosis for a cluster of chronic diseases","volume":"9","author":"Wilkins","year":"2019","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.clnesp.2026.105004_bib30","article-title":"Dietary factors as anti-inflammatory and neuroprotective agents in mental disorders: a comprehensive review","volume":"16","author":"Pa\u0142kowska-Go\u017adzik","year":"2024","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.clnesp.2026.105004_bib31","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/bcp.14094","article-title":"Prescribing medicines to older people: how to consider the impact of ageing on human organ and body functions","volume":"86","author":"Drenth-van Maanen","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105004_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/092986710790416326","article-title":"Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions","volume":"17","author":"Corsonello","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clnesp.2026.105004_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/IJGM.S291964","article-title":"Sex and gender differences in treatment efficacy of irritable bowel syndrome: a systematic review","volume":"14","author":"Van Kessel","year":"2021","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgend Health"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105004_bib35","first-page":"193","article-title":"Health indicators and health service utilization patterns of transgender veterans: a comparison study","volume":"3","author":"Lehavot","year":"2016","journal-title":"LGBT Health"},{"key":"10.1016\/j.clnesp.2026.105004_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annepidem.2019.09.009","article-title":"Psychiatric disorders in the U.S. transgender population","volume":"39","author":"Hanna","year":"2019","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105004_bib37","first-page":"345","article-title":"Practical tips for surgical research: blinding: who, what, when, why, how?","volume":"53","author":"Karanicolas","year":"2010","journal-title":"Can J Surg"},{"key":"10.1016\/j.clnesp.2026.105004_bib38","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1136\/bmj.e1119","article-title":"Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"344","author":"Hr\u00f3bjartsson","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2026.105004_bib39","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clnesp.2026.105004_bib40","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clnesp.2026.105004_bib41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.14309\/ajg.0000000000001732","article-title":"Optimal design of clinical trials of dietary interventions in disorders of gut-brain interaction","volume":"117","author":"Staudacher","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2026.105004_bib42","series-title":"Dietary reference intakes for calcium and vitamin D","year":"2011"},{"issue":"5","key":"10.1016\/j.clnesp.2026.105004_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/endrev\/bnae009","article-title":"Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows","volume":"45","author":"Giustina","year":"2024","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.clnesp.2026.105004_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080847","article-title":"Personalised interventions\u2014a precision approach for the next generation of dietary intervention studies","volume":"9","author":"De Roos","year":"2017","journal-title":"Nutrients"},{"issue":"Suppl 7","key":"10.1016\/j.clnesp.2026.105004_bib45","first-page":"S7","article-title":"Effectiveness of nutrition and dietary interventions for people with serious mental illness: systematic review and meta-analysis","volume":"217","author":"Rocks","year":"2022","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105004_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clnesp.2026.105004_bib48","series-title":"Average annual wages","year":"2024"},{"key":"10.1016\/j.clnesp.2026.105004_bib49","series-title":"Wages and labour costs \u2013 Eurostat","year":"2024"},{"key":"10.1016\/j.clnesp.2026.105004_bib50","series-title":"Middle income countries","year":"2024"},{"key":"10.1016\/j.clnesp.2026.105004_bib51","unstructured":"World Bank. GNI per capita, Atlas method (current US$). Washington (DC): The World Bank. https:\/\/data.worldbank.org\/indicator\/NY.GNP.PCAP.CD."},{"key":"10.1016\/j.clnesp.2026.105004_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2017.08.026","article-title":"Effects of omega-3 in the treatment of violent schizophrenia patients","volume":"195","author":"Qiao","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clnesp.2026.105004_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2020.11.050","article-title":"Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: a randomized clinical trial","volume":"228","author":"Szeszko","year":"2021","journal-title":"Schizophr Res"},{"issue":"9","key":"10.1016\/j.clnesp.2026.105004_bib54","first-page":"1863","article-title":"Quality assessment of omega-3 supplements available in the Brazilian market","volume":"29","author":"Galuch","year":"2018","journal-title":"J Braz Chem Soc"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1079\/BJN20051720","article-title":"Microalgal docosahexaenoic acid decreases plasma triacylglycerols in normolipemic vegetarians: a randomized trial","volume":"95","author":"Geppert","year":"2006","journal-title":"Br J Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2026.105004_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clnesp.2026.105004_bib58","series-title":"official Gazette of the Union","article-title":"Resolution RE no. 3,669, of November 4, 2022","year":"2022"},{"key":"10.1016\/j.clnesp.2026.105004_bib59","series-title":"Office of Dietary Supplements. Ashwagandha: is it helpful for stress, anxiety, or sleep?","year":"2023"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib60","first-page":"606","article-title":"Probiotic use in autism spectrum disorder and schizophrenia: a narrative literature review","volume":"19","author":"Gon\u00e7alves","year":"2020","journal-title":"Rev Ci\u00eanc M\u00e9d Biol"},{"key":"10.1016\/j.clnesp.2026.105004_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102361","article-title":"The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Amirani","year":"2020","journal-title":"Compl Ther Med"},{"issue":"9","key":"10.1016\/j.clnesp.2026.105004_bib62","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1590\/1413-81232021269.21342020","article-title":"A systematic review on the effects of probiotics on depression and anxiety: an alternative therapy?","volume":"26","author":"Minayo","year":"2021","journal-title":"Ci\u00eancia Sa\u00fade Coletiva"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-021-03308-w","article-title":"The psychotropic effect of vitamin D supplementation on schizophrenia symptoms","volume":"21","author":"Neriman","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.clnesp.2026.105004_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clnesp.2023.01.005","article-title":"Influence of hypovitaminosis D during pregnancy on glycemic and lipid profile, inflammatory indicators and anthropometry of pregnant and newborn","volume":"54","author":"Santos","year":"2023","journal-title":"Clin Nutr ESPEN"},{"issue":"8263","key":"10.1016\/j.clnesp.2026.105004_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","article-title":"Increased skin pigment reduces the capacity of skin to synthesize vitamin D3","volume":"1","author":"Clemens","year":"1982","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clnesp.2026.105004_bib66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clnesp.2026.105004_bib67","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI112134","article-title":"Aging decreases the capacity of human skin to produce vitamin D3","volume":"76","author":"MacLaughlin","year":"1985","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.clnesp.2026.105004_bib68","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2012-2020","article-title":"The effect of vitamin D on calcium absorption in older women","volume":"97","author":"Gallagher","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2026.105004_bib69","series-title":"Ultra-processed foods, diet quality, and health using the NOVA classification system","author":"Monteiro","year":"2019"},{"issue":"15","key":"10.1016\/j.clnesp.2026.105004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/su12156280","article-title":"Ultra-processed foods and food system sustainability: what are the links?","volume":"12","author":"Fardet","year":"2020","journal-title":"Sustainability"},{"issue":"12","key":"10.1016\/j.clnesp.2026.105004_bib71","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/nu10122000","article-title":"Seafood consumption, omega-3 fatty acids intake, and life-time prevalence of depression in the PREDIMED-Plus trial","volume":"10","author":"S\u00e1nchez-Villegas","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2026.105004_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0791-y","article-title":"A randomised controlled trial of dietary improvement for adults with major depression (the \u2018SMILES\u2019 trial)","volume":"15","author":"Jacka","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.clnesp.2026.105004_bib73","series-title":"Food guide for the Brazilian population","year":"2014"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726021017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726021017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:32:43Z","timestamp":1790019163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726021017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":73,"alternative-id":["S2405457726021017"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105004","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive nutritional interventions in schizophrenia: A systematic review of randomised clinical trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105004"}}